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Background: Epidemiologic evidence suggests a negative relation between sunlight exposure 
and breast cancer risk. The hypothesized mechanism is sunlight-induced cutaneous synthesis 
of vitamin D.
oBjectives: Our goal was to examine sun exposure and its inter action with vitamin D receptor 
(VDR) gene variants on breast cancer risk.
Methods: We examined sun exposure and breast cancer incidence among 31,021 private pesticide 
applicators’ wives, including 578 cases, enrolled in the prospective Agricultural Health Study cohort 
and followed 8.6 years on average. We estimated inter actions between sun exposure, VDR variants, 
and breast cancer in a nested case– control study comprising 293 cases and 586 matched controls. 
Information on sun exposure was obtained by questionnaire at cohort enrollment. Relative risks 
were estimated using Cox proportional hazards regression for the cohort data and conditional logistic 
regression for the nested case– control data.
results: We observed a small decrease in breast cancer risk in association with usual sun exposure 
of ≥ 1 hr/day (versus < 1 hr/day) 10 years before the start of follow-up among all participants [haz-
ard ratio (HR) = 0.8; 95% CI: 0.6, 1.0]. The association appeared to be slightly stronger in relation 
to estrogen receptor–positive tumors (HR = 0.7; 95% CI: 0.5, 0.9) than estrogen receptor–negative 
tumors (HR = 1.1; 95% CI: 0.6, 2.1). The HR for joint exposure ≥ 1 hr/day of sunlight and one 
VDR haplotype was less than expected given negative HRs for each individual exposure (inter action 
p-value = 0.07).
conclusion: Our results suggest that sun exposure may be associated with reduced risk of breast 
cancer, but we did not find clear evidence of modification by VDR variants. Larger studies are 
warranted, particularly among populations in whom low levels of usual sun exposure can be more 
precisely characterized.
citation: Engel LS, Satagopan J, Sima CS, Orlow I, Mujumdar U, Coble J, Roy P, Yoo S, 
Sandler DP, Alavanja MC. 2014. Sun exposure, vitamin D receptor genetic variants, and risk of 
breast cancer in the Agricultural Health Study. Environ Health Perspect 122:165–171; http://
dx.doi.org/10.1289/ehp.1206274
Background
Epidemiologic studies have reported a 
negative relation between sunlight expo-
sure and risk of breast cancer. The hypoth-
esized mechanism for this relationship 
is sunlight (ultraviolet B)–induced dermal 
synthesis of vitamin D, which experimen-
tal and non experimental evidence suggests 
may reduce risk of several cancers, includ-
ing breast cancer. Dermal synthesis is the 
primary source of vitamin D for most indi-
viduals, with diet and supplements gener-
ally being minor contributors (Holick 2007). 
In dermal synthesis, 7-dehydrocholesterol 
in the skin is converted to vitamin D3, 
which is then hydroxylated in the liver to 
the pro hormone 25-hydroxy vitamin D 
[25(OH)D], the princi pal circulating form of 
vitamin D. 25(OH)D is converted primarily 
in the kidneys to 1,25-dihydroxyvitamin D 
[1,25(OH)2D], the biologically active form 
of vitamin D, which exerts a range of anti-
carcinogenic effects (Holick 2007; Krishnan 
and Feldman 2011). Thus, sunlight and 
other factors that affect circulating levels of 
25(OH)D may influence cancer risk.
Most cohort and case– control studies that 
have examined sunlight and/or ultraviolet 
light (UV) exposure—either through self-
reported personal behaviors or via ambient 
levels at place of residence—have reported 
evidence of a negative association with breast 
cancer (Anderson et al. 2011b; Engel et al. 
2011; John et al. 1999, 2007; Knight et al. 
2007; Millen et al. 2009; Yang et al. 2011). 
In addition, several ecologic studies have 
reported negative correlations between mea-
sures of sunlight exposure (based on latitude, 
regional monitoring data, or acid haze) and 
breast cancer incidence (Grant 2010; Mohr 
et al. 2008) or mortality (Garland et al. 1990; 
Gorham et al. 1989; Grant 2002, 2010). 
Results from studies of serum 25(OH)D levels 
and breast cancer risk have been inconsistent, 
which may be due to differences in the tim-
ing of serum 25(OH)D measurement rela-
tive to cancer diagnosis (Gandini et al. 2011); 
the inadequacy of a single blood sample in 
many populations for assessing individuals’ 
usual  circulating 25(OH)D levels, which vary 
by season and possibly over years (Rejnmark 
et al. 2006); or to the possibility of false-posi-
tive findings in some studies.
1,25(OH)2D exerts most of its known 
physiological effects through binding to 
the vitamin D receptor (VDR) (Krishnan 
and Feldman 2011). The VDR, which is 
expressed in normal breast tissue and most 
breast tumors (Welsh et al. 2003), regu-
lates transcription of genes involved in 
cellu lar growth, differentiation, apoptosis, 
angiogenesis, and metastasis (Guyton et al. 
2003; Krishnan and Feldman 2011; Lowe 
et al. 2003). Experimental studies on mam-
mary tumor cell lines from VDR-knockout 
mice have shown that VDR is necessary 
for 1,25(OH)2D to induce cell cycle arrest 
and apoptosis in breast cancer cells (Zinser 
et al. 2003). In addition, the susceptibility of 
breast and other tissues to tumorigenesis was 
reported to be increased in VDR-deficient 
mice (Bouillon et al. 2008). The VDR is 
encoded by a large gene containing 14 exons 
that span approximately 75 kb (Crofts et al. 
1998; Miyamoto et al. 1997).
In the present study we investigated 
the risk of breast cancer in relation to sun 
exposure and its inter action with VDR gene 
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variants among wives of farmers in a large, 
prospective, two-state agricultural cohort. 
This population has a very wide range of sun 
exposure; detailed, prospective data on demo-
graphic, lifestyle, and occupational factors; 
and a high rate of follow-up. This research 
was motivated in part by previous reports of 
reduced risks of breast cancer among female 
farmers and agricultural workers relative to 
the general population (Duell et al. 2000; 
Fleming et al. 1999; Pukkala and Notkola 
1997; Wiklund and Dich 1994).
Methods
Study population. Participants were wives of 
private pesticide applicators, mainly farmers, 
from Iowa and North Carolina who enrolled 
in the prospective Agricultural Health Study 
(AHS) cohort between 1993 and 1997 
(Alavanja et al. 1996). A total of 32,127 wives 
(75% of those eligible) enrolled in the cohort 
via self-administered questionnaire. Cancer 
cases were identified through population-based 
cancer registries in Iowa and North Carolina, 
and vital status was ascertained through state 
death registries and the National Death Index 
(http://www.cdc.gov/nchs/ndi.htm). Estrogen 
receptor (ER) and progesterone receptor (PR) 
status of the tumor was available from the 
registries for 475 (82.2%) and 447 (77.3%) 
cases, respectively. Excluding 1,106 wives 
with a malignant cancer diagnosis other than 
non melanoma skin cancer before enrollment 
left 31,021 participants for the present cohort 
analy ses. Among these, 578 were diagnosed 
with malignant breast cancer [International 
Classification of Diseases for Oncology, 2nd edi-
tion (Percy et al. 1990), codes C50.0–C50.9] 
between enrollment and 31 December 2004. 
In addition, 23,676 wives (74% of those 
enrolled) completed a follow-up telephone 
interview approximately 5 years after enroll-
ment, at which time approximately 60% pro-
vided a mouthwash rinse sample for extraction 
of buccal cell DNA. More than 98% of the 
wives in this cohort were white, and 99% were 
non-Hispanic. The nested case– control study 
included 293 incident breast cancer cases with 
a mouthwash sample (50.7% of eligible cases) 
and two controls with mouthwash samples 
who were randomly matched with replace-
ment to each case by race (white, Hispanic 
and non-Hispanic; other), state (Iowa, North 
Carolina), age at enrollment (5-year age 
groups), and enrollment period (1993–1995, 
1996–1997). In addition, on the diagnosis 
date of a given case, eligible controls also had 
to be alive, have no cancer diagnoses, and be 
living in the same state as the case. A total of 
879 cases and controls were selected. Because 
controls were selected with replacement, which 
provides an unbiased sample from the cohort 
(Rothman and Greenland 1998), 19 partici-
pants were each selected as controls for 2 cases, 
and 4 participants were each selected as both 
a control and, at a later time point, a case. 
Cohort members who returned a mouthwash 
sample were similar to those who did not with 
regard to a range of demographic, lifestyle, 
and medical factors, suggesting that selection 
bias related to provision of a biospecimen is 
unlikely to substantially influence estimated 
associations (Engel et al. 2002). Only 263 
women (0.8% of all participants) were lost 
to follow-up. The average follow-up duration 
was 8.6 years. Participants provided informed 
consent for the AHS. The institutional review 
boards of the National Institutes of Health 
and its contractors approved the AHS. The 
institutional review boards of Memorial Sloan-
Kettering Cancer Center and the University of 
North Carolina at Chapel Hill approved the 
present study.
Exposure assessment. All sun exposure 
information was obtained at cohort enroll-
ment. Questions included a) “In the grow-
ing season, how many hours a day do you 
generally spend in the sun?” at enrollment 
and also 10 years before enrollment, with 
choices of < 1, 1–2, 3–5, 6–10, > 10 hr/day, 
and b) “In the growing season when you work 
in the sun, what type(s) of sun protection do 
you usually use?” with choices of sunscreen/ 
sunblock, baseball-type cap, other kind of hat 
with brim, long-sleeved shirt, or none of the 
above. The questionnaires also elicited infor-
mation on a range of demographic, lifestyle, 
health, agricultural, and reproductive factors. 
Pre diagnostic data on menopausal status and 
age at menopause were also obtained from 
5-year follow-up interviews. (Questionnaires 
are available at http://www.aghealth.org.)
Genotyping in the nested case– control 
study. Twenty-six single nucleotide poly-
morphisms (SNPs) in VDR [rs2544038, 
rs739837, rs731236 (TaqI), rs2239182, 
rs2107301, rs2239181, rs2238139, rs2189480, 
rs3782905, rs7974708, rs11168275, 
r s2408876,  r s1989969,  r s2238135, 
rs10875694, rs3922882, rs11168287, 
rs7299460, rs11168314, rs4073729, 
rs3923693, rs4760674, rs6823, rs2071358, 
rs7975232 (ApaI), rs2228570 (FokI)] were 
geno typed, as described in our related work 
(Engel et al. 2012). The VDR haplotype struc-
ture of our study population was comparable 
to that observed among whites by Nejentsev 
et al. (2004), so linkage dis equilibrium blocks 
were defined using the naming convention of 
Nejentsev et al. (2004).
Data analy sis. We estimated associations 
between breast cancer and usual sun expo-
sure, both at enrollment and 10 years before 
enrollment, using the five exposure categories 
specified in the questionnaire. For the nested 
case– control analy ses, the upper two catego-
ries were combined because of small sample 
numbers. The lowest category (< 1 hr/day) was 
used as the reference category in all analy ses. 
The majority of women (84.5%) reported the 
same levels of sun exposure during the two 
time periods. Therefore, we estimated associa-
tions according to time period using separate 
models and did not create a composite expo-
sure estimate. We also estimated the associa-
tion between breast cancer and sun exposure 
for ≥ 1 hr/day compared with < 1 hr/day.
Cohort study of sun exposure. We used 
Cox proportional hazards regression to calcu-
late hazard ratios (HRs) and 95% confidence 
intervals (CIs) for the association between 
breast cancer and each measure of sunlight 
exposure. Person-years at risk for each partici-
pant were calculated from date of enrollment 
until the earliest of the following: first breast 
cancer diagnosis, first malignant non-breast 
cancer diagnosis (excluding non melanoma 
skin cancer), movement out of state, death, 
or 31 December 2004. All analy ses were 
adjusted for known breast cancer risk factors, 
including age (< 40, 40–49, 50–59, 60–69, 
≥ 70 years), race (white, Hispanic and non-
Hispanic; other), age at menopause (premeno-
pausal, < 45, 45–49, 50–54, ≥ 55 years, with 
status allowed to change during follow-up, 
based on self-reported age at which partici-
pant had her last menstrual period), and first-
degree family history of breast cancer (yes, 
no). Analyses were additionally adjusted for 
state (Iowa, North Carolina) and for com-
bined parity and age at first birth (1 birth, by 
age 30 years; ≥ 2 births, first by age 30 years; 
nulliparous or all births after age 30 years), 
with nulliparous women and those with first 
births after age 30 years combined because of 
the small number of nulliparous cases (n = 6). 
Body mass index, age at menarche, smoking 
status, and education were not included in 
the final models because they did not change 
risk estimates by at least 10%. Time-varying 
covariates (menopausal status, age at meno-
pause) were classified at each time point based 
on the most recent value reported; only values 
reported before the end of follow-up for each 
participant were used.
We also performed analy ses stratified by 
ER/PR status, menopausal status at diagnosis, 
family history of breast cancer, and usual use 
of sunscreen. We included only women with 
non-missing data for a given stratification fac-
tor, including all non cases in each analy sis by 
ER/PR status and menopausal status.
Nested case– control study of sun expo-
sure and gene–environment inter action. 
Conditional logistic regression was used 
to estimate odds ratios (ORs) and 95% CIs 
for usual sun exposure and inter actions 
with genetic variants. Because the geno type 
data were unphased, we estimated expected 
haplo types and their frequencies using the 
haplo.stats software (Sinnwell and Schaid 2013) 
in R, version 2.3 (R Foundation for Statistical 
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Computing, Vienna, Austria). We used these 
as independent variables in regression models 
(Kraft et al. 2005) together with sun exposure 
(< 1 hr/day, ≥ 1 hr/day) and a product term. 
We examined only the most common 50% 
of haplotypes in each linkage disequilibrium 
block, comprising six haplotypes in block B and 
seven haplotypes in block C (Engel et al. 2012) 
(see Supplemental Material, Table S2). We 
present inter action results in the tables only for 
SNPs and haplotypes that either had significant 
main effects in univariate analy ses (p < 0.05) 
or showed evidence of departure from multi-
plicativity in inter action analy ses. The multi-
plica tive inter action between sun exposure 
and each SNP was evaluated via the statistical 
signifi cance (p < 0.05) of the likelihood ratio 
test comparing the models with and without 
the product term. All analy ses were adjusted 
for age at menopause, combined parity and 
age at first birth, and first-degree family history 
of breast cancer, as described above, based on 
status at enrollment.
There was insufficient DNA for geno-
typing for 23 cases and 32 controls. To 
account for missing geno type and sun exposure 
data, we used the missing-indicator method 
(Huberman and Langholz 1999) in our analy-
sis of gene–sun inter actions. This method 
allows all participants to be included in analy-
ses and maintains case– control matching, and 
produces an OR estimate that is a compromise 
(i.e., a weighted average) between the estimates 
from a matched analy sis of complete sets and 
an unmatched analy sis of incomplete sets. 
Analysis confirmed lack of heterogeneity in 
ORs between complete sets and incomplete 
sets, which is necessary for the validity of this 
method (Huberman and Langholz 1999).
In both the cohort and the case– control 
analy ses, missing data for adjustment covari-
ates were imputed using IVEware (Institute 
for Social Research, University of Michigan, 
Ann Arbor, MI). This program, which 
assumes an ignorable-missing-data mecha-
nism, simultaneously imputes values for 
specified variables by fitting a sequence of 
regression models and drawing values from 
the corresponding predictive distributions. 
Missing values were imputed for race (3.2%), 
family history of breast cancer (5.0%), parity 
(17.6%), and age at menopause (2.0%). Risk 
estimates including imputed data were not 
materially different from those including only 
observed data, so we present risk estimates 
adjusted using the imputed and observed data.
All statistical analy ses were performed using 
SAS, version 9.1 (SAS Institute Inc., Cary, 
NC), except where otherwise noted. Statistical 
significance was assessed at the 5% level. Tests 
for trend were assessed using midpoints of cate-
gories as continuous measures. In analy ses of 
covariate risk (Table 1; see also Supplemental 
Material, Table S1), all covariates were adjusted 










18–39 55 (9.5) 9,747 (32.0) 1 (Reference)
40–49 141 (24.4) 8,775 (28.8) 2.8 (2.1, 3.9)
50–59 214 (37.0) 7,025 (23.1) 5.6 (4.0, 8.0)
60–69 127 (22.0) 3,938 (12.9) 6.2 (4.2, 9.2)
70–86 41 (7.1) 958 (3.2) 8.6 (5.4, 13.7)
Race  
White (Hispanic and non-Hispanic) 547 (98.2) 28,962 (98.2) 1 (Reference)
Other 10 (1.8) 517 (1.8) 0.9 (0.5, 1.8)
Missing 21 964  
State of residence  
Iowa 362 (62.6) 20,469 (67.2) 1 (Reference)
North Carolina 216 (37.4) 9,974 (32.8) 1.1 (0.9, 1.3)
Highest educational level  
< High school 30 (6.0) 1,435 (5.4) 0.7 (0.5, 1.1)
High school 223 (44.2) 10,604 (40.1) 0.9 (0.8, 1.1)
> High school 251 (49.8) 14,412 (54.5) 1 (Reference)
Missing 74 3,992  
Smoking  
Never 394 (73.1) 20,772 (72.4) 1 (Reference)
Former 105 (19.5) 4,925 (17.2) 1.2 (0.9, 1.7)
Current 40 (7.4) 3,003 (10.5) 1.3 (0.9, 1.9)
Missing 39 1,743  
First-degree family history of breast cancer  
Yes 114 (20.9) 3,289 (11.4) 1.8 (1.4, 2.2)
No 431 (79.1) 25,643 (88.6) 1 (Reference)
Missing 33 1,511  
Body mass index (kg/m2)  
< 25.0 191 (44.6) 10,417 (50.6) 1 (Reference)
25.0–29.9 143 (33.4) 6,472 (31.4) 1.0 (0.8, 1.2)
≥ 30.0 94 (22.0) 3,709 (18.0) 1.2 (1.0, 1.6)
Missing 150 9,845  
Age at menarche (years)  
< 12 54 (13.4) 2,790 (15.4) 1 (Reference)
12–14 315 (78.0) 13,710 (75.5) 0.9 (0.7, 1.2)
≥ 15 35 (8.7) 1,656 (9.1) 1.0 (0.7, 1.4)
Missing 174 12,287  
Parity  
Nulliparous 6 (1.2) 621 (2.5) 0.9 (0.4, 2.0)
1 54 (10.7) 2,359 (9.4) 1.2 (0.9, 1.7)
≥ 2 444 (88.1) 22,075 (88.1) 1 (Reference)
Missing 74 5,388  
Age at first birth (years)b  
≤ 20 91 (24.8) 3,889 (23.4) 1 (Reference)
20–30 239 (65.1) 11,700 (70.3) 1.0 (0.7, 1.2)
> 30 37 (10.1) 1,044 (6.3) 1.8 (1.2, 2.6)
Missing 131 7,801  
Menopausal status  
Post menopausal 325 (64.5) 11,054 (43.0) 0.9 (0.7, 1.1)
Pre menopausal 179 (35.5) 14,663 (57.0) 1 (Reference)
Missing 74 4,726  
Age at menopause (years)c  
< 45 102 (32.2) 4,249 (39.2) 1 (Reference)
45–49 81 (25.6) 2,659 (24.5) 1.0 (0.7, 1.3)
50–54 107 (33.8) 3,085 (28.5) 1.1 (0.8, 1.4)
≥ 55 27 (8.5) 846 (7.8) 1.0 (0.6, 1.5)
Missing 8 215  
Usual sunblock use at enrollment  
Yes 242 (41.9) 12,943 (42.5) 1.0 (0.8, 1.2)
No 336 (58.1) 17,500 (57.5) 1 (Reference)
Tumor ER status
ER+ 315 (75.0) NA
ER– 105 (25.0) NA
Missing 158
Tumor PR status
PR+ 280 (67.3) NA
PR– 136 (32.7) NA
Missing 162
NA, not applicable.
aHRs were estimated using Cox proportional hazards regression, with all factors adjusted for the other factors in 
the table, except where indicated, and with no imputed data. bRestricted to parous women, with no imputed data. 
 cRestricted to post menopausal women, with no imputed data.
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for the other covariates, except where indicated, 
and with no imputed data. We did not adjust 
p-values for multiple comparisons because of 
the exploratory nature of our genetic analy-
ses. Analyses were based on AHS data releases 
P1REL0506.01 and P2REL0506.04.
Results
Selected characteristics of the women in the 
cohort and in the nested case– control study 
are provided in Table 1 (see also Supplemental 
Material, Table S1). Most of the women in 
the cohort (60.3%) were under 50 years of 
age at enrollment, although, as expected, 
cases were on average older than non cases/
controls. Over 67% of the participants lived in 
Iowa. Almost all of the women (97.5%) had 
had at least one birth and about 43% were 
postmenopausal at enrollment. Distributions 
of most demographic and lifestyle factors 
were similar for the 578 cases in the cohort 
(Table 1) and the 293 cases included in the 
nested case– control study (see Supplemental 
Material, Table S1). However, a slightly 
larger proportion of cases in the nested case– 
control study than in the cohort were from 
Iowa (66.9% vs. 62.6%) and had education 
beyond high school (54.8% vs. 49.8%). 
Approximately 98% of both the cohort and 
the case– control sample were white.
Sun exposure. The range of sun expo-
sure during the growing season among study 
participants was very wide (Table 2). Usual 
sun exposure of ≥ 6 hr/day was reported by 
12.4% of participants who provided informa-
tion on sun exposure for the period around 
enrollment and by 21.8% of those who pro-
vided information for the period 10 years 
before enrollment, whereas 27.0% and 17.9% 
reported < 1 hr/day for each of these periods, 
respectively. Sun exposure data were missing 
for 29–33% of the participants.
We found little evidence of a decreasing 
dose–response relation between usual sun 
exposure and breast cancer risk for expo-
sure either at enrollment or 10 years before 
enrollment (Table 2). However, we observed 
a small decreased risk associated with usual 
sun exposure of ≥ 1 hr/day compared with 
< 1 hr/day 10 years before enrollment 
(HR = 0.8; 95% CI: 0.6, 1.0) in the cohort, 
with similar associations for participants in 
Iowa (HR = 0.7; 95% CI: 0.5, 1.0) and North 
Carolina (HR = 0.8; 95% CI: 0.6, 1.2). At 
least 75% of North Carolina participants and 
84% of Iowa participants resided in the same 
state 10 years before enrollment. As expected, 
patterns of association were similar between 
women in the cohort and women in the nested 
case– control study.
Negative associations with sun exposure 
appeared to be limited to women with no 
family history of breast cancer (for sun expo-
sure ≥ 1 hr/day vs. < 1 hr/day 10 years before 
enrollment, HR = 0.7; 95% CI: 0.6, 0.9 and 
1.2; 95% CI: 0.6, 2.1 among women with-
out and with a family history, respectively) 
(Table 3). The negative association with sun 
exposure also appeared to be limited to women 
with ER+ tumors [for sun exposure ≥ 1 hr/day 
versus < 1 hr/day 10 years before enrollment, 
HR = 0.7; 95% CI: 0.5, 0.9 and 1.1; 95% CI: 
0.6, 2.1 for ER+ (n = 315) and ER– (n = 105) 
tumors, respectively]. We observed no evi-
dence of differences in associations by meno-
pausal status, usual use of sunscreen/sunblock, 
or PR status of the tumor (Table 3).
Adjustment for self-reported duration 
of pesticide use and self-reported measures 
of occupational and recreational physical 
activity from the enrollment questionnaire 
did not materially alter risk estimates (data 
not shown). Results were also similar in 
sub analy ses restricted to whites (data not 
shown), which was expected given the small 
 proportion of nonwhites in this study.
Table 3. HRs for sunlight exposure ≥ 1 hr/day and breast cancer risk among wives in the cohort, stratified 
by selected factors [cases (n = 578), non cases (n = 30,443)].
Characteristic Cases (n) Noncases (n)
Usual hours of sun 
exposure per day 
at enrollment 
[adjusted HRa (95% CI)]
Usual hours of sun 
exposure per day  
10 years before enrollment 
[adjusted HRa (95% CI)]
Menopausal status
Premenopausal 179 14,663 1.0 (0.7, 1.4) 0.8 (0.5, 1.1)
Postmenopausal 325 11,054 0.9 (0.7, 1.1) 0.8 (0.6, 1.1)
Usual use of sunscreen/sunblock
Yes 242 12,943 0.9 (0.7, 1.1) 0.7 (0.5, 1.0)
No 336 17,500 0.9 (0.7, 1.2) 0.8 (0.6, 1.2)
Family history of breast cancer
Yes 114 3,289 1.3 (0.8, 2.1) 1.2 (0.6, 2.1)
No 431 25,643 0.8 (0.7, 1.1) 0.7 (0.6, 0.9)
Tumor ER status
ER+ 315 NA 0.9 (0.7, 1.2) 0.7 (0.5, 0.9)
ER– 105 NA 0.7 (0.4, 1.1) 1.1 (0.6, 2.1)
Tumor PR status
PR+ 280 NA 0.9 (0.7, 1.2) 0.7 (0.5, 1.0)
PR– 136 NA 0.7 (0.5, 1.1) 0.8 (0.5, 1.2)
aHRs were estimated using Cox proportional hazards regression adjusted for age (< 40, 40–49, 50–59, 60–69, ≥ 70 years), 
race (white, other), state (Iowa, North Carolina), age at menopause (premenopausal, < 45, 45–49, 50–54, ≥ 55 years), com-
bined parity and age at first birth (1 birth, by age 30 years; ≥ 2 births, first by age 30 years; nulliparous or all births after age 
30 years), and first-degree family history of breast cancer (yes, no). Factors that are being stratified on are not adjusted 
for in those models. Missing covariate data were imputed using IVEware, a multivariate sequential regression approach.
Table 2. Sunlight exposure and breast cancer risk among wives in the cohort [cases (n = 578), non cases 
(n = 30,443)] and in the nested case– control study [cases (n = 293), non cases (n = 586)].
Characteristic













Usual hours of sun exposure per day at enrollment
< 1 hr 139 (30.8) 5,804 (26.9) 1 (Reference) 78 (31.5) 142 (29.9) 1 (Reference)
1–2 hr 136 (30.2) 6,962 (32.3) 0.9 (0.7, 1.1) 71 (28.6) 148 (31.2) 0.8 (0.5, 1.2)
3–5 hr 125 (27.7) 6,129 (28.4) 0.9 (0.7, 1.2) 72 (29.0) 123 (25.9) 1.0 (0.7, 1.6)
6–10 hr 43 (9.5) 2,156 (10.0) 0.9 (0.7, 1.3) 21 (8.5) 52 (10.9) 0.8 (0.4, 1.3)b
> 10 hr 8 (1.8) 521 (2.4) 0.7 (0.3, 1.4) 6 (2.4) 10 (2.1)  
< 1 hr 139 (30.8) 5,804 (26.9) 1 (Reference) 78 (31.5) 142 (29.9) 1 (Reference)
≥ 1 hr 312 (69.2) 15,768 (73.1) 0.9 (0.7, 1.1) 170 (68.5) 333 (70.1) 0.9 (0.6, 1.2)
Missing 127 8,871  45 111  
Usual hours of sun exposure per day 10 years before enrollment  
< 1 hr 92 (21.7) 3,592 (17.8) 1 (Reference) 57 (24.4) 88 (19.3) 1 (Reference)
1–2 hr 103 (24.3) 5,224 (25.8) 0.8 (0.6, 1.1) 54 (23.1) 103 (22.6) 0.7 (0.5, 1.2)
3–5 hr 133 (31.4) 6,967 (34.5) 0.8 (0.6, 1.0) 74 (31.6) 154 (33.8) 0.7 (0.5, 1.1)
6–10 hr 75 (17.7) 3,569 (17.6) 0.8 (0.6, 1.1) 36 (15.4) 88 (19.3) 0.6 (0.4, 1.0)c
> 10 hr 20 (4.7) 869 (4.3) 0.9 (0.5, 1.4) 13 (5.6) 22 (4.8)  
< 1 hr 92 (21.7) 3,592 (17.8) 1 (Reference) 57 (24.4) 88 (19.3) 1 (Reference)
≥ 1 hr 331 (78.3) 16,629 (82.2) 0.8 (0.6, 1.0) 177 (75.6) 367 (80.7) 0.7 (0.5, 1.0)
Missing 155 10,222 59 131
aHRs were estimated using Cox proportional hazards regression adjusted for age (< 40, 40–49, 50–59, 60–69, ≥ 70 years), 
race (white, other), state (Iowa, North Carolina), age at menopause (premenopausal, < 45, 45–49, 50–54, ≥ 55 years), 
combined parity and age at first birth (1 birth, by age 30 years; ≥ 2 births, first by age 30 years; nulliparous or all births 
after age 30 years), and first-degree family history of breast cancer (yes, no). bORs were estimated using conditional 
logistic regression, matched on age at enrollment, race, and state, and adjusted for age at menopause, combined parity 
and age at first birth, and first-degree family history of breast cancer, as for the cohort analyses. Missing covariate data 
were imputed using IVEware, a multivariate sequential regression approach. cThe upper two categories—6–10 hr and 
> 10 hr—were combined in nested case– control analyses because of small sample  numbers.
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Gene–environment inter actions. Tables 4 
and 5 present results for only the five SNPs 
and three haplotypes, respectively, that 
either had significant main effects in univari-
ate analy ses (p < 0.05) or showed evidence 
of departure from multiplicativity in inter-
action analy ses. The inter action between 
rs2239181 and usual sun exposure 10 years 
before enrollment on breast cancer risk 
showed some evidence of a departure from 
multiplicativity (Table 4). Among those with 
the T/T geno type at rs2239181, usual sun 
exposure ≥ 1 hr/day was associated with a 
30% decrease in the odds of breast cancer 
(OR = 0.7; 95% CI: 0.4, 1.1) relative to usual 
sun exposure < 1 hr/day. In contrast, among 
those with T/G or G/G geno types (com-
bined), usual sun exposure ≥ 1 hr/day was 
associated with only a 14% decrease in the 
odds of breast cancer relative to those with 
usual sun exposure < 1 hr/day (OR = 1.2 vs. 
OR = 1.4; inter action p-value = 0.06). We 
found no evidence of departure from multi-
plicativity between other SNPs and usual sun 
exposure 10 years before enrollment.
There  was  a  sugge s t ion  o f  sub-
mul t ip l i c a t i v i t y  be tween  hap lo type 
TCAGCTTCGCA (haplotype “B6”) and 
usual sun exposure ≥ 1 hr/day 10 years before 
enrollment; however, this was not significant 
(inter action p-value = 0.07) (Table 5). Among 
carriers of the TCAGCTTCGCA haplotype, 
sun exposure was not associated with the odds 
of breast cancer: The ORs associated with 
sun exposure ≥ 1 hr/day and sun exposure 
< 1 hr/day were both 0.6. In contrast, 
among non carriers of this haplotype, sun 
exposure was associated with a 50% decrease 
in breast cancer odds (OR = 0.5; 95% CI: 
0.3, 0.9). Results did not differ substantively 
between subgroups defined by family history 
of breast cancer or use of sun protection, 
or in subanaly ses restricted to whites (data 
not shown).
Discussion
Results from this large, prospective cohort 
study of women living and/or working on 
farms suggest that sunlight exposure may be 
associated with a reduced risk of breast cancer, 
particularly for ER+ tumors. The timing of sun 
exposure may be important because exposure 
10 years before start of follow-up was negatively 
associated with breast cancer, whereas sun expo-
sure at the start of follow-up was not, although 
this difference could be due to other factors 
such as missing data. There was some evidence 
that the association between usual sun exposure 
and risk of breast cancer was  modified by one 
of the 13 haplotypes evaluated.
Our findings regarding sunlight exposure 
and breast cancer risk are consistent with 
most previous studies on this topic. Negative 
associations have been observed in both case– 
control studies (Anderson et al. 2011b; Knight 
et al. 2007) and cohort studies (Engel et al. 
2011; John et al. 1999, 2007; Millen et al. 
2009; Yang et al. 2011). Measures of sunlight 
exposure that have been negatively associ-
ated with breast cancer include self-reported 
Table 4. Selected inter actions between genetic polymorphisms and usual sun exposure 10 years before 
enrollment on breast cancer risk among wives in the nested case– control study [cases (n = 293), non-
cases (n = 586)].a
Genotype











T/T < 1 16 26 1 (Reference)
T/T ≥ 1 45 120 0.5 (0.3, 1.1)
T/C < 1 24 45 0.9 (0.4, 2.0)
T/C ≥ 1 84 160 0.8 (0.4, 1.6)
C/C < 1 12 11 1.9 (0.6, 5.4)
C/C ≥ 1 31 57 0.9 (0.4, 1.9) 0.12
rs2239181
T/T < 1 38 63 1 (Reference)
T/T ≥ 1 132 302 0.7 (0.4, 1.1)
T/G or G/G < 1 14 18 1.4 (0.6, 3.2)
T/G or G/G ≥ 1 32 44 1.2 (0.6, 2.3) 0.06
rs11168287
A/A < 1 11 23 1 (Reference)
A/A ≥ 1 52 87 1.2 (0.5, 2.6)
A/G < 1 29 42 1.5 (0.6, 3.5)
A/G ≥ 1 83 175 0.9 (0.4, 2.0)
G/G < 1 12 17 1.3 (0.5, 3.9)
G/G ≥ 1 24 71 0.7 (0.3, 1.6) 0.26
rs739837
T/T < 1 14 31 1 (Reference)
T/T ≥ 1 56 94 1.2 (0.6, 2.5)
T/G < 1 21 33 1.3 (0.6, 3.1)
T/G ≥ 1 75 157 1.0 (0.5, 1.9)
G/G < 1 17 19 1.8 (0.7, 4.6)
G/G ≥ 1 33 93 0.7 (0.3, 1.5) 0.13
rs7975232
A/A < 1 14 31 1 (Reference)
A/A ≥ 1 56 94 1.2 (0.6, 2.5)
A/C < 1 21 33 1.3 (0.6, 3.1)
A/C ≥ 1 77 160 1.0 (0.5, 1.9)
C/C < 1 17 19 1.8 (0.7, 4.6)
C/C ≥ 1 32 94 0.6 (0.3, 1.4) 0.10
aTable includes inter action results only for SNPs (of 26 evaluated) that either had significant main effects in univariate 
analyses (p < 0.05) or showed evidence of departure from multiplicativity in inter action analyses. bBecause some 
members of matched case– control sets had missing information on sun exposure or geno type, the missing-indicator 
method was used to retain all participants (ncases = 293, ncontrols = 586) and maintain case– control matching (see text). 
cORs were estimated using conditional logistic regression, with matching on age at enrollment (5-year age groups), race 
(white, other), and state (Iowa, North Carolina), and adjusted for age at menopause (premenopausal, < 45, 45–49, 50–54, 
≥ 55 years), combined parity and age at first birth (1 birth, by age 30 years; ≥ 2 births, first by age 30 years; nulliparous 
or all births after age 30 years), and first-degree family history of breast cancer (yes, no). Missing covariate data 
were imputed using IVEware, a multivariate sequential regression approach. dBased on model assuming codominant 
polymorphisms and dichotomous sun exposure and a multiplicative inter action term between them.
Table 5. Selected inter actionsa between haplo-
types in block Bb and usual sun exposure 10 years 
before enrollment on breast cancer risk among 











Not B4 < 1 1 (Reference)
Not B4 ≥ 1 0.7 (0.5, 1.1)
B4 < 1 0.6 (0.2, 1.5)
B4 ≥ 1 0.3 (0.2, 0.5) 0.69
B5: TCAGCTTACTA
Not B5 < 1 1 (Reference)
Not B5 ≥ 1 0.7 (0.4, 1.0)
B5 < 1 0.8 (0.4, 1.5)
B5 ≥ 1 0.7 (0.5, 0.8) 0.51
B6: TCAGCTTCGCA
Not B6 < 1 1 (Reference)
Not B6 ≥ 1 0.5 (0.3, 0.9)
B6 < 1 0.6 (0.4, 1.0)
B6 ≥ 1 0.6 (0.5, 0.7) 0.07
aTable  includes inter action results only for haplotypes 
(of 13 evaluated) that either had significant main effects 
in univariate analyses (p < 0.05) or showed evidence 
of departure from multiplicativity in inter action analy-
ses. bBlocks based on Nejentsev et  al. (2004), with 
order of SNPs in block B as follows: rs739837, rs731236, 
rs7975232, rs2239182, rs2107301, rs2239181, rs2238139, 
rs2189480, rs3782905, rs7974708, rs11168275. cORs were 
estimated using conditional logistic regression, with 
matching on age at enrollment (5-year age groups), race 
(white, other), and state (Iowa, North Carolina), and 
adjusted for age at menopause (premenopausal, < 45, 
45–49, 50–54, ≥ 55 years), combined parity and age at 
first birth (1 birth, by age 30 years; ≥ 2 births, first by age 
30 years; nulliparous or all births after age 30 years), and 
first-degree family history of breast cancer (yes, no). 
Missing covariate data were imputed using IVEware, a 
multivariate sequential regression approach.
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time spent outdoors in daylight (Anderson 
et al. 2011b; John et al. 1999; Knight et al. 
2007; Millen et al. 2009) and cumulative sun 
exposure estimates based on reflectometric 
measurement of skin pigmentation (John 
et al. 2007). Extent of sun-seeking vacations 
and solarium use were negatively associated 
with breast cancer risk in a cohort of 42,559 
Swedish women followed for an average 
of 14.9 years (Yang et al. 2011) but not in 
a cohort of 41,811 Norwegian women fol-
lowed for an average of 8.5 years (Edvardsen 
et al. 2011). Ecologic studies, while providing 
weaker evidence, also have been largely consis-
tent in showing a negative correlation between 
breast cancer risk and potential UV exposure, 
based on average ground-level solar energy 
(Garland et al. 1990; Gorham et al. 1990), 
latitude (Grant 2010), or acid haze (Gorham 
et al. 1989). The reason for the observed dif-
ference in association by timing of exposure 
in our study is unclear. Some studies have sug-
gested stronger associations at younger ages 
(Knight et al. 2007; Yang et al. 2011), which 
would be generally consistent with our find-
ings, although other studies have found similar 
associations across age groups (Anderson et al. 
2011b; John et al. 2007).
We found no evidence of a dose–response 
relation between self-reported sun exposure 
≥ 1 hr/day and breast cancer risk, but the 
relative risk of breast cancer did appear to 
be reduced in association with ≥ 1 hr/day of 
usual sun exposure compared with < 1 hr/day. 
The exposure distribution in this occupation-
ally exposed population is likely skewed high 
compared with general population samples 
in previous studies. However, once individu-
als achieve a circulating 25(OH)D level of 
about 40 ng/mL, the effects of additional 
sun/UV exposure appear to become blunted, 
with a much lower rate of increase in circu-
lating 25(OH)D per unit of sun exposure 
(Hollis 2005). Self-reported exposure infor-
mation reflecting usual behavior over a long 
time period may be too imprecise to measure 
incremental reductions in risk from longer 
durations of sun exposure.
We observed no modification of the asso-
ciation between sunlight exposure and breast 
cancer risk by sunscreen use, which is consis-
tent with the lack of association between sun-
screen use and breast cancer risk reported in 
other studies (Anderson et al. 2011b; Knight 
et al. 2007; Kuper et al. 2009). This may be 
due to the fact that many people apply insuf-
ficient sunscreen and do not reapply it as fre-
quently as needed (Norval and Wulf 2009). 
Indeed, sunscreen use can be a poor predictor 
of 25(OH)D levels (Thieden et al. 2009).
Evidence that the relationship between 
vitamin D and breast cancer risk differs by 
hormone receptor status of the tumor is 
conflicting. Blackmore et al. (2008), in a 
population- based study of 759 cases and 1,135 
controls, observed reduced risks of similar 
magnitude for ER+/PR+ tumors, ER–/PR– 
tumors, and ER+/PR– tumors associated with 
increased vitamin D intake via sun and diet. In 
contrast, a study involving 1,019 incident cases 
within the prospective Women’s Health Study 
(Lin et al. 2007) and another study involving 
2,855 incident cases within the prospective 
Cancer Prevention Study II Nutrition Cohort 
(McCullough et al. 2005) reported stronger 
negative associations between dietary vita-
min D intake and both ER+ or PR+ tumors. 
However, a study of 2,440 incident cases 
within the prospective Iowa Women’s Health 
Study observed stronger negative associations 
with ER– or PR– tumors (Robien et al. 2007). 
In vitro studies suggest that ER+ breast cancer 
cell lines are generally more sensitive than ER– 
cell lines to 1,25(OH)2D–mediated growth 
regulation (Welsh et al. 2002).
Studies that have examined inter actions 
between VDR variants and markers of 
vitamin D —including sun exposure, serum 
25(OH)D, and dietary vitamin D intake—on 
breast cancer risk have produced inconsistent, 
but largely null, results. A case– control study 
of breast cancer reported limited evidence of 
an inter action between BsmI (rs1544410) 
geno type and serum 25(OH)D concentra-
tions measured in blood samples collected after 
diagnosis (Lowe et al. 2005). A case– control 
study that examined seven of the same poly-
morphisms as the present study (rs731236, 
rs739837, rs1989969, rs2228570, rs7975232, 
rs2107301, rs2238135) found, like the pres-
ent study, no significant inter actions between 
sun exposure and these polymorphisms 
(Anderson et al. 2011a). However, Anderson 
et al. (2011a) did observe a significant inter-
action between dietary vitamin D intake and 
rs2238135. Other studies have reported no 
modification of associations between measured 
or inferred vitamin D status and breast cancer 
by the VDR polymorphisms BsmI (Chen et al. 
2005; McCullough et al. 2007), FokI (Abbas 
et al. 2008; Chen et al. 2005; John et al. 2007; 
McCullough et al. 2007), TaqI (Abbas et al. 
2008; John et al. 2007; McCullough et al. 
2007), or ApaI (rs7975232, also evaluated in 
the present study) (McCullough et al. 2007).
Limitations of this study include use of 
self-reported usual sun exposure, which likely 
introduced some exposure misclassification. 
However, studies indicate that reliability of 
recall of usual or total sun exposure is good, 
with interclass correlation coefficients of 
about 0.7–0.8 (English et al. 1998; Rosso 
et al. 2002); that self-reported sun exposure 
correlates with circulating 25(OH)D levels 
(Hanwell et al. 2010; Sowers et al. 1986); 
and that reliability of reporting for a range 
of factors among Agricultural Health Study 
participants is good to excellent, with percent 
agreements of 50–60% for measures of pes-
ticide use and 71–76% for amount of alco-
hol and tobacco use (Blair et al. 2002). The 
appreciable amount of missing sun exposure 
data may have introduced some bias in the 
present study. About 22% of cases and 29% 
of non cases were missing data on usual sun 
exposure at enrollment, whereas 29% of cases 
and 34% of non cases were missing data on 
usual sun exposure 10 years before enrollment. 
The reasons for the differences in percent 
missing are unclear. However, any exposure 
misclassification among those who provided 
sun exposure information in this study is likely 
nondifferential with regard to disease status 
because exposure information was collected 
before breast cancer diagnosis. As in any study, 
there may also be uncontrolled confounding, 
although we evaluated a wide range of poten-
tial confounders and included any that were 
found to affect risk estimates. Although the 
5-year follow-up interview may have occurred 
after breast cancer diagnosis for some cases, 
only covariate data collected before diagnosis 
for the cases and their matched controls were 
included in this study. Also, the minimum 
sun exposure category in the questionnaire was 
up to 1 hr, and the rate of vitamin D synthe-
sis per amount of sun exposure may decrease 
within this time period. Nonetheless, evidence 
suggests that vitamin D levels continue to 
rise with increasing sun exposure above levels 
attainable through casual exposure (Adams 
et al. 1982; Haddad and Chyu 1971) and 
our cohort had a very wide range of exposure. 
Although we examined only sun exposure as 
a vitamin D source in the present study, sun 
exposure accounts for the large majority of 
circulating 25(OH)D in most people (Holick 
2007). The relatively small sample size of the 
nested case– control study limited our ability 
to estimate inter actions. In addition, some 
observed associations may be due to chance 
because of the number of comparisons per-
formed. Last, the generalizability of this study 
may be limited primarily to whites because 
of the small proportion of non whites in the 
study population and differences in vitamin D 
synthesis by skin color.
Strengths of this study include collection 
of all information on exposures and covari-
ates before disease diagnosis; thus, any mis-
classification was likely nondifferential with 
regard to disease status. In addition, this cohort 
is large and includes a substantial number of 
incident cases. Follow-up of this cohort is 
excellent. Also, this cohort has an unusually 
wide range of usual sun exposure compared 
with the general population, with a substan-
tial proportion of women in the upper end 
of the exposure distribution providing greater 
exposure contrasts, although no dose–response 
association was observed. Reliability of report-
ing for a range of lifestyle and occupational 
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factors is good to excellent in this cohort (Blair 
et al. 2002). Finally, this study had detailed 
data at baseline and at 5 years on potential 
 confounders and effect modifiers.
Conclusion
Our results suggest that sun exposure may 
be associated with reduced risk of breast 
cancer, but we did not find clear evidence 
of modification of this association by vari-
ants in the VDR gene. Our results further 
suggest that this association may be stronger 
for ER+ tumors, although these analy ses are 
based on a relatively small sample size. Larger 
studies, particularly among populations in 
which usual sun exposure at the low end can 
be more precisely characterized, are warranted 
to help clarify this relationship.
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